Adjuvant Aflibercept for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
European Physician Survey of EGFR Inhibitor Prescribing Patterns
- Status
- COMPLETED
- Phase
- N/A
Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
- Status
- UNKNOWN
- Phase
- N/A
Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharmacokinetics and Metabolic Activation of Capecitabine
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
2nd-line Treatment of Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland
- Status
- RECRUITING
- Phase
- N/A
Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3